Numerous studies have highlighted the significant role of UBE2C in tumor progression, such as in endometrial cancer [15], head and neck squamous cell carcinoma [16], breast cancer [17], and lung cancer [18]. This evidence concerns the gene UBE2C and breast carcinoma.